These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

774 related articles for article (PubMed ID: 26799587)

  • 1. Knockdown of long non-coding RNA TP73-AS1 inhibits cell proliferation and induces apoptosis in esophageal squamous cell carcinoma.
    Zang W; Wang T; Wang Y; Chen X; Du Y; Sun Q; Li M; Dong Z; Zhao G
    Oncotarget; 2016 Apr; 7(15):19960-74. PubMed ID: 26799587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA TP73-AS1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Clear Cell Renal Cell Carcinoma Through Repressing KISS1 Expression and Inactivation of PI3K/Akt/mTOR Signaling Pathway.
    Liu G; Zhao X; Zhou J; Cheng X; Ye Z; Ji Z
    Cell Physiol Biochem; 2018; 48(1):371-384. PubMed ID: 30016766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA TP73-AS1 sponges miR-141-3p to promote the migration and invasion of pancreatic cancer cells through the up-regulation of BDH2.
    Cui XP; Wang CX; Wang ZY; Li J; Tan YW; Gu ST; Qin CK
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30643007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulated lncRNA TP73-AS1 reduces radioresistance in hepatocellular carcinoma via the PTEN/Akt signaling pathway.
    Song W; Zhang J; Xia Q; Sun M
    Cell Cycle; 2019 Nov; 18(22):3177-3188. PubMed ID: 31564201
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhanced expression of lncRNA TP73-AS1 predicts adverse phenotypes for cholangiocarcinoma and exerts oncogenic properties in vitro and in vivo.
    Yao Y; Sun Y; Jiang Y; Qu L; Xu Y
    Biomed Pharmacother; 2018 Oct; 106():260-266. PubMed ID: 29966969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGFα.
    Cai Y; Yan P; Zhang G; Yang W; Wang H; Cheng X
    Cancer Biomark; 2018; 23(1):145-156. PubMed ID: 30010111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA TP73-AS1 promoted the progression of lung adenocarcinoma via PI3K/AKT pathway.
    Liu C; Ren L; Deng J; Wang S
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30541897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA PEG10 regulates proliferation and invasion of esophageal cancer cells.
    Zang W; Wang T; Huang J; Li M; Wang Y; Du Y; Chen X; Zhao G
    Cancer Gene Ther; 2015 Apr; 22(3):138-44. PubMed ID: 25591808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA TP73-AS1 predicts the prognosis of bladder cancer patients and functions as a suppressor for bladder cancer by EMT pathway.
    Tuo Z; Zhang J; Xue W
    Biochem Biophys Res Commun; 2018 May; 499(4):875-881. PubMed ID: 29625110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical role for the long non-coding RNA AFAP1-AS1 in the proliferation and metastasis of hepatocellular carcinoma.
    Lu X; Zhou C; Li R; Liang Z; Zhai W; Zhao L; Zhang S
    Tumour Biol; 2016 Jul; 37(7):9699-707. PubMed ID: 26803513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA ZEB1-AS1 down-regulation suppresses the proliferation and invasion by inhibiting ZEB1 expression in oesophageal squamous cell carcinoma.
    Zhao Y; Wang N; Zhang X; Liu H; Yang S
    J Cell Mol Med; 2019 Dec; 23(12):8206-8218. PubMed ID: 31638344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of long non-coding RNA TP73-AS1 inhibits osteosarcoma cell proliferation and invasion through sponging miR-142.
    Yang G; Song R; Wang L; Wu X
    Biomed Pharmacother; 2018 Jul; 103():1238-1245. PubMed ID: 29864904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lncRNA TP73-AS1 promotes ovarian cancer cell proliferation and metastasis via modulation of MMP2 and MMP9.
    Wang X; Yang B; She Y; Ye Y
    J Cell Biochem; 2018 Sep; 119(9):7790-7799. PubMed ID: 29904939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced expression of lncRNA TP73-AS1 predicts unfavorable prognosis for gastric cancer and promotes cell migration and invasion by induction of EMT.
    Zhang W; Zhai Y; Wang W; Cao M; Ma C
    Gene; 2018 Dec; 678():377-383. PubMed ID: 30118890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of long noncoding RNA TP73-AS1 suppresses the malignant progression of breast cancer cells in vitro through targeting miRNA-125a-3p/metadherin axis.
    Liu Y; Wei G; Ma Q; Han Y
    Thorac Cancer; 2020 Feb; 11(2):394-407. PubMed ID: 31901156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA FOXP4-AS1 is an unfavourable prognostic factor and regulates proliferation and apoptosis in colorectal cancer.
    Li J; Lian Y; Yan C; Cai Z; Ding J; Ma Z; Peng P; Wang K
    Cell Prolif; 2017 Feb; 50(1):. PubMed ID: 27790757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2.
    Wu Y; Hu L; Liang Y; Li J; Wang K; Chen X; Meng H; Guan X; Yang K; Bai Y
    Mol Cancer; 2017 Aug; 16(1):150. PubMed ID: 28854977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Long Non-Coding RNA, SOX21-AS1, Indicates a Poor Prognosis and Promotes Lung Adenocarcinoma Proliferation.
    Lu X; Huang C; He X; Liu X; Ji J; Zhang E; Wang W; Guo R
    Cell Physiol Biochem; 2017; 42(5):1857-1869. PubMed ID: 28873379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of long non-coding RNA ZEB1-AS1 in esophageal squamous cell carcinoma and its correlation with tumor progression and patient survival.
    Wang YL; Bai Y; Yao WJ; Guo L; Wang ZM
    Int J Clin Exp Pathol; 2015; 8(9):11871-6. PubMed ID: 26617942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. lncRNA CCAT1 is a biomarker for the proliferation and drug resistance of esophageal cancer via the miR-143/PLK1/BUBR1 axis.
    Hu M; Zhang Q; Tian XH; Wang JL; Niu YX; Li G
    Mol Carcinog; 2019 Dec; 58(12):2207-2217. PubMed ID: 31544294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.